Phase I Study of Palbociclib Alone and in Combination in Patients With Relapsed and Refractory (R/R) Leukemias
Phase of Trial: Phase I
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Palbociclib (Primary) ; Decitabine; Dexamethasone; Sorafenib
- Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia
- Focus Adverse reactions
- 02 Aug 2017 Planned End Date changed from 1 Sep 2020 to 1 Jul 2020.
- 02 Aug 2017 Planned primary completion date changed from 1 Sep 2020 to 1 Jul 2020.
- 02 Aug 2017 Status changed from not yet recruiting to recruiting.